Clinical Trial Update: A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two Rituximab-containing chemotherapy regimens with a PET-driven strategy in lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Lymphoma, B-Cell, Lymphoma, Large-Cell, Diffuse | Phase 2 | Status: COMPLETED